BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38266696)

  • 1. Bisphenol F exposure induces depression-like changes: Roles of the kynurenine metabolic pathway along the "liver-brain" axis.
    Yu Z; Lin Y; Wu L; Wang L; Fan Y; Xu L; Zhang L; Wu W; Tao J; Huan F; Liu W; Wang J; Gao R
    Environ Pollut; 2024 Apr; 346():123356. PubMed ID: 38266696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.
    Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse chronic social stress increases blood and brain kynurenine pathway activity and fear behaviour: Both effects are reversed by inhibition of indoleamine 2,3-dioxygenase.
    Fuertig R; Azzinnari D; Bergamini G; Cathomas F; Sigrist H; Seifritz E; Vavassori S; Luippold A; Hengerer B; Ceci A; Pryce CR
    Brain Behav Immun; 2016 May; 54():59-72. PubMed ID: 26724575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice.
    Zhou M; Fan Y; Xu L; Yu Z; Wang S; Xu H; Zhang J; Zhang L; Liu W; Wu L; Yu J; Yao H; Wang J; Gao R
    Microbiome; 2023 Jun; 11(1):145. PubMed ID: 37386523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
    Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
    Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan-kynurenine metabolic characterization in the gut and brain of depressive-like rats induced by chronic restraint stress.
    Li CC; Ye F; Xu CX; Jiang N; Chang Q; Liu XM; Pan RL
    J Affect Disord; 2023 May; 328():273-286. PubMed ID: 36746244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the kynurenine metabolism pathway by Xiaoyao San and the underlying effect in the hippocampus of the depressed rat.
    Wang J; Li X; He S; Hu L; Guo J; Huang X; Hu J; Qi Y; Chen B; Shang D; Wen Y
    J Ethnopharmacol; 2018 Mar; 214():13-21. PubMed ID: 29217494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma.
    Sordillo LA; Sordillo PP
    Anticancer Res; 2023 Dec; 43(12):5275-5282. PubMed ID: 38030171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
    Mouri A; Hasegawa M; Kunisawa K; Saito K; Nabeshima T
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):233-237. PubMed ID: 36990795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glia- and tissue-specific changes in the Kynurenine Pathway after treatment of mice with lipopolysaccharide and dexamethasone.
    Dostal CR; Gamsby NS; Lawson MA; McCusker RH
    Brain Behav Immun; 2018 Mar; 69():321-335. PubMed ID: 29241670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of different chronic restraint stress periods on anxiety- and depression-like behaviors and tryptophan-kynurenine metabolism along the brain-gut axis in C57BL/6N mice.
    Ye F; Dong MC; Xu CX; Jiang N; Chang Q; Liu XM; Pan RL
    Eur J Pharmacol; 2024 Feb; 965():176301. PubMed ID: 38145646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: Focus on cell type differences.
    Fujigaki H; Yamamoto Y; Saito K
    Neuropharmacology; 2017 Jan; 112(Pt B):264-274. PubMed ID: 26767951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
    Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
    Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease.
    Mazarei G; Budac DP; Lu G; Adomat H; Tomlinson Guns ES; Möller T; Leavitt BR
    J Neurochem; 2013 Dec; 127(6):852-67. PubMed ID: 23786539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.
    Wang XD; Notarangelo FM; Wang JZ; Schwarcz R
    Brain Res; 2012 May; 1455():1-9. PubMed ID: 22498176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
    Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
    PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women.
    Wang SY; Duan KM; Tan XF; Yin JY; Mao XY; Zheng W; Wang CY; Yang M; Peng C; Zhou HH; Liu ZQ
    J Affect Disord; 2017 Jun; 215():94-101. PubMed ID: 28319697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.